ControlRad announced today that it received FDA 510(k) clearance to market its ControlRad Select radiation reduction technology. Atlanta-based ControlRad’s technology uses proprietary semi-transparent filters with a user-interface tablet and imaging processing algorithms that are retrofitted onto customers’ existing Siemens Artis zee interventional imaging systems, according to a news release. ControlRad, ahead of its commercialization efforts […]
ControlRad
ControlRad adds five people to leadership team
ControlRad announced today that it made several additions to its leadership team, naming a new chief financial officer, VP of U.S. operations, VP of marketing and two new VPs of sales. The Atlanta-based company named Peter Pizzo as its new CFO. Pizzo has more than 25 years of experience in senior financial roles, having previously […]
ControlRad drums up $15m Series B round
ControlRad said today that it completed a $15 million Series B round for the commercial launch of its Trace system for reducing radiation in fluoroscopically guided procedures. Norcross, Ga.-based ControlRad’s Trace system is the first FDA-cleared technology that can be integrated into existing mobile C-arms to reduce the ionizing radiation that can occur in FGP. […]
ControlRad touts first use for Trace radiation exposure reduction tech
ControlRad today said it completed the first clinical use of its Trace system. Atlanta-based ControlRad’s Trace technology can be integrated into mobile C-arms to help reduce radiation in fluoroscopically guided procedures. The company said it can reduce radiation exposure by up to 89% to protect patients and medical staff without having to compromise image quality […]
NuVasive shuffles the deck | Personnel Moves
NuVasive Inc. (NSDQ:NUVA) announced a flurry of new executive assignments yesterday as it reorganizes its leadership team under new CEO Gregory Lucier, who took over the position in May from ousted Alex Lukianov. NuVasive 14-year vet Pat Miles will stay on as COO and president, a position he was appointed to earlier this year, NuVasive said. […]
